- Home
- LAES vs APTO Comparison
LAES vs APTO Comparison
Compare LAES & APTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAES
- APTO
- Stock Information
- Founded
- LAES 2022
- APTO 1986
- Country
- LAES Switzerland
- APTO Canada
- Employees
- LAES N/A
- APTO N/A
- Industry
- LAES Semiconductors
- APTO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LAES Technology
- APTO Health Care
- Exchange
- LAES Nasdaq
- APTO Nasdaq
- Market Cap
- LAES 10.7M
- APTO 11.5M
- IPO Year
- LAES N/A
- APTO N/A
- Fundamental
- Price
- LAES $2.33
- APTO $0.18
- Analyst Decision
- LAES Strong Buy
- APTO Strong Buy
- Analyst Count
- LAES 1
- APTO 3
- Target Price
- LAES $1.75
- APTO $4.33
- AVG Volume (30 Days)
- LAES 49.6M
- APTO 1.4M
- Earning Date
- LAES 09-25-2024
- APTO 11-08-2024
- Dividend Yield
- LAES N/A
- APTO N/A
- EPS Growth
- LAES N/A
- APTO N/A
- EPS
- LAES N/A
- APTO N/A
- Revenue
- LAES $20,135,000.00
- APTO N/A
- Revenue This Year
- LAES N/A
- APTO N/A
- Revenue Next Year
- LAES N/A
- APTO N/A
- P/E Ratio
- LAES N/A
- APTO N/A
- Revenue Growth
- LAES N/A
- APTO N/A
- 52 Week Low
- LAES $0.29
- APTO $0.13
- 52 Week High
- LAES $3.95
- APTO $2.68
- Technical
- Relative Strength Index (RSI)
- LAES 83.63
- APTO 29.73
- Support Level
- LAES $0.35
- APTO $0.18
- Resistance Level
- LAES $3.46
- APTO $0.22
- Average True Range (ATR)
- LAES 0.30
- APTO 0.01
- MACD
- LAES 0.27
- APTO 0.01
- Stochastic Oscillator
- LAES 76.85
- APTO 22.50
About LAES SEALSQ Corp
SEALSQ Corp develops certified secure microcontrollers and implements post-quantum cryptography. The company develops solutions including post-quantum microchips and devices that can be used in a variety of applications, from multi-factor authentication, home automation, and IT network infrastructure to automotive, industrial automation, and control systems. Its vaultIC range offers a complete set of ready-to-use secure elements designed to implement embedded security for any kind of device with fast time-to-market and high flexibility. The company's products include VaultIC155, VaultIV18x, VaultIC292, and VaultIC40x. The company generates a majority of its revenue from North America.
About APTO Aptose Biosciences Inc.
Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The Company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities.